User profiles for Antoine Neuraz

Neuraz Antoine, MD, PhD

Université Paris Cité, France
Verified email at u-paris.fr
Cited by 2230

[HTML][HTML] Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study

…, R Vernet, N Beeker, AS Jannot, A Neuraz… - Molecular …, 2021 - nature.com
A prior meta-analysis showed that antidepressant use in major depressive disorder was
associated with reduced plasma levels of several pro-inflammatory mediators, which have been …

[HTML][HTML] Natural language processing for rapid response to emergent diseases: case study of calcium channel blockers and hypertension in the COVID-19 pandemic

A Neuraz, I Lerner, W Digan, N Paris, R Tsopra… - Journal of medical …, 2020 - jmir.org
Background A novel disease poses special challenges for informatics solutions. Biomedical
informatics relies for the most part on structured data, which require a preexisting data or …

Patient mortality is associated with staff resources and workload in the ICU: a multicenter observational study

A Neuraz, C Guérin, C Payet, S Polazzi… - Critical care …, 2015 - journals.lww.com
Objective: Matching healthcare staff resources to patient needs in the ICU is a key factor for
quality of care. We aimed to assess the impact of the staffing-to-patient ratio and workload on …

Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in …

…, M Bernaux, A Gramfort, N Lapidus, N Paris, A Neuraz… - MedRxiv, 2020 - medrxiv.org
Objective To assess the clinical effectiveness of oral hydroxychloroquine (HCQ) with or
without azithromycin (AZI) in preventing death or leading to hospital discharge. Design …

[HTML][HTML] International electronic health record-derived post-acute sequelae profiles of COVID-19 patients

…, B Moal, SN Murphy, ZH Strasser, A Neuraz… - NPJ digital …, 2022 - nature.com
The risk profiles of post-acute sequelae of COVID-19 (PASC) have not been well characterized
in multi-national settings with appropriate controls. We leveraged electronic health record …

[HTML][HTML] Diagnosis support systems for rare diseases: a scoping review

C Faviez, X Chen, N Garcelon, A Neuraz… - Orphanet Journal of …, 2020 - Springer
Introduction Rare diseases affect approximately 350 million people worldwide. Delayed
diagnosis is frequent due to lack of knowledge of most clinicians and a small number of expert …

[HTML][HTML] Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: an international multi-centre observational cohort study

…, K Cho, YL Ho, LP Patel, A Dagliati, A Neuraz… - …, 2023 - thelancet.com
Background While acute kidney injury (AKI) is a common complication in COVID-19, data
on post-AKI kidney function recovery and the clinical factors associated with poor kidney …

[HTML][HTML] What every reader should know about studies using electronic health record data but may be afraid to ask

…, M Daniar, JH Moore, SN Murphy, A Neuraz… - Journal of medical …, 2021 - jmir.org
Coincident with the tsunami of COVID-19–related publications, there has been a surge of
studies using real-world data, including those obtained from the electronic health record (EHR)…

Association between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID‐19: an observational multicenter study

…, C Cougoule, N Beeker, A Neuraz… - Clinical …, 2021 - Wiley Online Library
Several medications commonly used for a number of medical conditions share a property of
functional inhibition of acid sphingomyelinase (ASM), or FIASMA. Preclinical and clinical …

[HTML][HTML] A clinician friendly data warehouse oriented toward narrative reports: Dr. Warehouse

N Garcelon, A Neuraz, R Salomon, H Faour… - Journal of biomedical …, 2018 - Elsevier
Introduction Clinical data warehouses are often oriented toward integration and exploration
of coded data. However narrative reports are of crucial importance for translational research. …